MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30121 to 30140 of 30,876 approvalsPage 1507 of 1544

Berocca Energy

Issued: Apr 2, 2024
PT. Bayer Indonesia

Lefixime 400

Issued: Apr 2, 2024

Triplessin

Issued: Apr 2, 2024

Levocer

Issued: Apr 2, 2024

Lefixime 200

Issued: Apr 2, 2024

None

Issued: Apr 2, 2024

Droxisur 100

Issued: Apr 2, 2024

Fortipred

Issued: Apr 2, 2024

Provinerv

Issued: Sep 1, 2022

Cixtor-Z

Issued: Sep 1, 2022

Medroxcure

Issued: Sep 1, 2022

Amicyn

Issued: Sep 1, 2022

Medprazol IV

Issued: Sep 1, 2022

Bisolab

Issued: Sep 1, 2022

Qualcet

Issued: Sep 1, 2022

None

Issued: Sep 1, 2022

None

Issued: Sep 1, 2022

Fetusin

Issued: Sep 1, 2022

Balversa

Issued: Sep 1, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.